Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Mander

Rationale and Study Design of the Adaptive Study of IL-2 Dose on Regulatory T Cells in Type 1 Diabetes (DILT1D): A Non-Randomised, Open Label, Adaptive Dose Finding Trial

BMJ Open

Medicine

2014

English

Assay Used in Serum Screening for Down's Syndrome May Depend on Ethnic Make Up of Population

BMJ

1996

English

Related publications

Adaptive Dose Finding Based Ont-Statistic for Dose–response Trials

Statistics in Medicine

English

A Phase 1b/2, Open-Label, Dose-Escalation, and Dose-Confirmation Study of Eribulin Mesilate in Combination With Capecitabine

British Journal of Cancer

Cancer Research

Oncology

2019

English

Evaluating Dose Regimens of Apomorphine, an Open-Label Study

International Journal of Impotence Research

Urology

2003

English

Two Stage Adaptive Optimal Design With Applications to Dose-Finding Clinical Trials

English

A Double-Blinded Randomised Placebo-Controlled Phase II Trial to Evaluate High Dose Rifampicin for Tuberculous Meningitis: A Dose Finding Study

Antimicrobial Agents and Chemotherapy

Infectious Diseases

Pharmacology

2018

English

On the Therapeutic Scope of Low-Dose IL-2. Response To: ‘Circulating Regulatory T Cells Were Absolutelydecreased in Dermatomyositis/Polymyositispatients and Restored by Low-Dose IL-2’ by Zhang Et Al

Annals of the Rheumatic Diseases

English

Design of the Myechild Trial, an International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia Incorporating an Embedded Dose Finding Study

English

Rationale and Study Design for a Randomised Controlled Trial to Reduce Sedentary Time in Adults at Risk of Type 2 Diabetes Mellitus: Project Stand (Sedentary Time ANd Diabetes)

English

The Neuroprotection With Statin Therapy for Acute Recovery Trial (Neustart): An Adaptive Design Phase I Dose-Escalation Study of High-Dose Lovastatin in Acute Ischemic Stroke

International Journal of Stroke

Neurology

2008

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Mander

Rationale and Study Design of the Adaptive Study of IL-2 Dose on Regulatory T Cells in Type 1 Diabetes (DILT1D): A Non-Randomised, Open Label, Adaptive Dose Finding Trial

Assay Used in Serum Screening for Down's Syndrome May Depend on Ethnic Make Up of Population

Related publications

Adaptive Dose Finding Based Ont-Statistic for Dose–response Trials

A Phase 1b/2, Open-Label, Dose-Escalation, and Dose-Confirmation Study of Eribulin Mesilate in Combination With Capecitabine

Evaluating Dose Regimens of Apomorphine, an Open-Label Study

Two Stage Adaptive Optimal Design With Applications to Dose-Finding Clinical Trials

A Double-Blinded Randomised Placebo-Controlled Phase II Trial to Evaluate High Dose Rifampicin for Tuberculous Meningitis: A Dose Finding Study

On the Therapeutic Scope of Low-Dose IL-2. Response To: ‘Circulating Regulatory T Cells Were Absolutelydecreased in Dermatomyositis/Polymyositispatients and Restored by Low-Dose IL-2’ by Zhang Et Al

Design of the Myechild Trial, an International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia Incorporating an Embedded Dose Finding Study

Rationale and Study Design for a Randomised Controlled Trial to Reduce Sedentary Time in Adults at Risk of Type 2 Diabetes Mellitus: Project Stand (Sedentary Time ANd Diabetes)

The Neuroprotection With Statin Therapy for Acute Recovery Trial (Neustart): An Adaptive Design Phase I Dose-Escalation Study of High-Dose Lovastatin in Acute Ischemic Stroke